BioCentury | Jun 29, 2019
Finance

Specialists and strong fundamentals must carry the sector in 3Q19

...Intelligence Buyer Seller Date Upfront cash ($M) Upfront stock ($M) Milestones ($M) Disclosed value ($M) Bracco Imaging S.p.A....
BioCentury | Jun 27, 2019
Financial News

Syncona reaps tenfold return from Blue Earth exit

...scale, and will also drive new company launches, the firm's CEO Martin Murphy told BioCentury. Bracco Imaging S.p.A....
...89% stake in Blue Earth, and expects a net return of £337 million ($428.9 million). Bracco...
...gene therapy company Nightstar Therapeutics plc (NASDAQ:NITE) this year (see "Biogen to Acquire Nightstar" ). Bracco...
BioCentury | Aug 17, 2015
Clinical News

Vitaros alprostadil regulatory update

...Vitaros in Spain, Russia, Turkey, Ireland and certain other European and undisclosed countries in Africa. Bracco...
BioCentury | Oct 20, 2014
Clinical News

Sulfur hexafluoride lipid-type A microspheres regulatory update

...FDA approved Lumason sulfur hexafluoride lipid-type A microspheres from Bracco as an ultrasound contrast agent. The...
...reactions. The product is marketed as SonoVue outside the U.S., including countries in the EU. Bracco...
BioCentury | Feb 3, 2014
Clinical News

Vitaros alprostadil regulatory update

...see BioCentury, Jan. 6). Warner Chilcott plc (NASDAQ:WCRX, Dublin, Ireland) has U.S. commercialization rights, and Bracco...
BioCentury | Jan 6, 2014
Clinical News

Vitaros alprostadil regulatory update

...the drug in Germany. Warner Chilcott plc (NASDAQ:WCRX, Dublin, Ireland) has U.S. commercialization rights, and Bracco...
BioCentury | Jan 6, 2014
Company News

Apricus Biosciences, Novartis sales and marketing update

...commercialize Vitaros in the U.K., Warner Chilcott plc (NASDAQ:WCRX, Dublin, Ireland) has U.S. commercialization rights, Bracco...
BioCentury | Dec 9, 2013
Clinical News

Vitaros alprostadil regulatory update

...market the drug in Germany. Warner Chilcott plc (NASDAQ:WCRX, Dublin, Ireland) has U.S. commercialization rights, Bracco...
BioCentury | Nov 25, 2013
Company News

Apricus Biosciences, Laboratoires Majorelle sales and marketing update

...the drug in Germany. Warner Chilcott plc (NASDAQ:WCRX, Dublin, Ireland) has U.S. commercialization rights, and Bracco...
BioCentury | Oct 14, 2013
Clinical News

Vitaros alprostadil regulatory update

...the drug in Germany. Warner Chilcott plc (NASDAQ:WCRX, Dublin, Ireland) has U.S. commercialization rights and Bracco...
Items per page:
1 - 10 of 54
BioCentury | Jun 29, 2019
Finance

Specialists and strong fundamentals must carry the sector in 3Q19

...Intelligence Buyer Seller Date Upfront cash ($M) Upfront stock ($M) Milestones ($M) Disclosed value ($M) Bracco Imaging S.p.A....
BioCentury | Jun 27, 2019
Financial News

Syncona reaps tenfold return from Blue Earth exit

...scale, and will also drive new company launches, the firm's CEO Martin Murphy told BioCentury. Bracco Imaging S.p.A....
...89% stake in Blue Earth, and expects a net return of £337 million ($428.9 million). Bracco...
...gene therapy company Nightstar Therapeutics plc (NASDAQ:NITE) this year (see "Biogen to Acquire Nightstar" ). Bracco...
BioCentury | Aug 17, 2015
Clinical News

Vitaros alprostadil regulatory update

...Vitaros in Spain, Russia, Turkey, Ireland and certain other European and undisclosed countries in Africa. Bracco...
BioCentury | Oct 20, 2014
Clinical News

Sulfur hexafluoride lipid-type A microspheres regulatory update

...FDA approved Lumason sulfur hexafluoride lipid-type A microspheres from Bracco as an ultrasound contrast agent. The...
...reactions. The product is marketed as SonoVue outside the U.S., including countries in the EU. Bracco...
BioCentury | Feb 3, 2014
Clinical News

Vitaros alprostadil regulatory update

...see BioCentury, Jan. 6). Warner Chilcott plc (NASDAQ:WCRX, Dublin, Ireland) has U.S. commercialization rights, and Bracco...
BioCentury | Jan 6, 2014
Clinical News

Vitaros alprostadil regulatory update

...the drug in Germany. Warner Chilcott plc (NASDAQ:WCRX, Dublin, Ireland) has U.S. commercialization rights, and Bracco...
BioCentury | Jan 6, 2014
Company News

Apricus Biosciences, Novartis sales and marketing update

...commercialize Vitaros in the U.K., Warner Chilcott plc (NASDAQ:WCRX, Dublin, Ireland) has U.S. commercialization rights, Bracco...
BioCentury | Dec 9, 2013
Clinical News

Vitaros alprostadil regulatory update

...market the drug in Germany. Warner Chilcott plc (NASDAQ:WCRX, Dublin, Ireland) has U.S. commercialization rights, Bracco...
BioCentury | Nov 25, 2013
Company News

Apricus Biosciences, Laboratoires Majorelle sales and marketing update

...the drug in Germany. Warner Chilcott plc (NASDAQ:WCRX, Dublin, Ireland) has U.S. commercialization rights, and Bracco...
BioCentury | Oct 14, 2013
Clinical News

Vitaros alprostadil regulatory update

...the drug in Germany. Warner Chilcott plc (NASDAQ:WCRX, Dublin, Ireland) has U.S. commercialization rights and Bracco...
Items per page:
1 - 10 of 54